Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation， invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice

Lin Song， Xin Zhou， Hong-Jun Jia， Mei Du， Jin-Ling Zhang， Liang Li

1Oncology Department No. 2， Linyi People's Hospital of Shandong Province， Linyi City， Shandong Province， 276000 China

2Radiotherapy Technology Department， Linyi People's Hospital of Shandong Province， Linyi City， Shandong Province， 276000 China

Effect of hGC-MSCs from human gastric cancer tissue on cell proliferation， invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice

Lin Song1， Xin Zhou1， Hong-Jun Jia2?， Mei Du1， Jin-Ling Zhang1， Liang Li1

1Oncology Department No. 2， Linyi People's Hospital of Shandong Province， Linyi City， Shandong Province， 276000 China

2Radiotherapy Technology Department， Linyi People's Hospital of Shandong Province， Linyi City， Shandong Province， 276000 China

Article history：

Received 15 May 2016

Received in revised form 16 June 2016

Accepted 15 July 2016

Available online 20 August 2016

Gastric cancer

Mesenchymal stem cells

Proliferation

Invasion

Epithelial-mesenchymal transition

Objective： To study the effect of hGC-MSCs from human gastric cancer tissue on cell proliferation， invasion and epithelial-mesenchymal transition in tumor tissue of gastric cancer tumor-bearing mice. Methods： BABL/c nude mice were selected as experimental animals and gastric cancer tumor-bearing mice model were established by subcutaneous injection of gastric cancer cells， randomly divided into different intervention groups. hGC-MSCs group was given different amounts of gastric cancer cells for subcutaneous injection， PBS group was given equal volume of PBS for subcutaneous injection. Then tumor tissue volume were determined， tumor-bearing mice were killed and tumor tissues were collected， mRNA expression of proliferation， invasion， EMT related molecules were determined. Results： 4， 8，12， 16， 20 d after intervention， tumor tissue volume of hGC-MSCs group were significantly higher than those of PBS group and the more the number of hGC-MSCs， the higher the tumor tissue volume； mRNA contents of Ki-67， PCNA， Bcl-2， MMP-2， MMP-7， MMP-9， MMP-14，N-cadherin， vimentin， Snail and Twist in tumor tissue of hGC-MSCs group were higher than those of PBS group， and mRNA contents of Bax， TIMP1， TIMP2 and E-cadherin were lower than those of PBS group. Conclusions： hGC-MSCs from human gastric cancer tissue can promote the tumor growth in gastric cancer tumor-bearing mice， and the molecular mechanism includes promoting cell proliferation， invasion and epithelial-mesenchymal transition.

1. Introduction

Mesenchymal stem cells （MSCs） are the stem cells from mesoderm of early embryo development that have the features such as highly self-renewal ability， easily transferring into exogenous genes and oncolytic virus， and weak immunogenicity ［1-2］. Studiesin recent years have confirmed that stem cells have good affinity to solid tumors and participate in the occurrence and development of a variety of malignant tumors. MSCs in vitro isolation， culture and amplification are relatively easy， and they are the ideal carrier for the verification of malignant tumor pathogenesis and the targeted treatment of malignant tumors ［3-5］. However， the relationship between MSCs and the occurrence and development of gastric cancer is not yet clear at present， and in the following study， hGCMSCs from human gastric cancer tissue were isolated and cultured，and gastric cancer tumor-bearing mice model were established，aiming at verifying the effect of hGC-MSCs from human gastric cancer tissue on tumor growth of gastric cancer tumor-bearing mice through animal experiments.

2. Materials and methods

2.1. Materials

Human gastric cancer cell lines SGC-7901 were bought from the cell bank of Chinese academy of sciences， BABL/c nude mice were purchased by the university animal center ［license： SCXK （Su）2011-0003］， 1640 culture medium， fetal bovine serum and trypsin for cell culture were bought from Gibco Company， and the RNA extraction and PCR detection kits were bought from Beijing Tiangen Biotech Company.

2.2. Tumor-bearing mouse model establishment

SGC-7901 cell lines were recovered， then cultured with 1640 culture medium containing 10% fetal bovine serum， amplified and then digested with trypsin， cell density was adjusted to 5×107/mL，200 μL cell suspension was collected and subcutaneously inoculated in the back of BABL/c nude mice， the volume of tumor tissue was measured after 8d， and those with volume more than 0.1cm3 were collected for subsequent research.

2.3. Separate culture and injection of hGC-MSCs

Fresh gastric carcinoma tissue was collected， saved under aseptic conditions， sent to the super clean bench， cut up to tissue fragments of 1 mm3， then inoculated in a Petri dish for 2 h of adherence，culture medium was added for continuous incubation for 24 h， half the medium was changed， un-adhered tissue mass and cells were discarded， medium was changed every 3d， cells were digested and sub-cultured after 80%-90% of fusion， and hGC-MSCs were obtained for treatment. HGC-MSCs group received injection of 0.5×106， 1.0×106and 2.0×106hGC-MSCs respectively around the transplantation tumor， and PBS group received injection the same volume of PBS.

2.4. Determination of tumor tissue growth

（1） 0， 4， 8， 12， 16 and 20d after establishment of tumor-bearing mice model， the long diameter and short diameter of tumor were determined， and tumor tissue volume was calculated according to long diameter × short diameter× short diameter/2； （2） on the 21d，tumor-bearing mice were executed and anatomized to get tumor tissue， RNA extraction kit was used to extract RNA and reversetranscribe it into cDNA， PCR kit was used for amplification and detection， and mRNA contents of Ki-67， PCNA， Bcl-2， Bax， P53，MMP-2， MMP-7， MMP-9， MMP-14， TIMP1， TIMP2， E-cadherin，N-cadherin， Vimentin， Snail and Twist were calculated.

2.5. Statistical methods

SPSS20.0 software was used for analysis， differences among groups were compared by single factor analysis of variance， the pair-wise comparison was by LSD method and P＜0.05 indicated statistical significance in differences.

3. Results

3.1. hGC-MSCs promoted tumor tissue growth in tumorbearing mice

Different doses of hGC-MSCs could all promote the tumor tissue growth in tumor-bearing mice. At each point in time， tumor tissue volume of hGC-MSCs group were significantly higher than those of PBS group， and the larger the dose of hGC-MSCs， the more significant the increase of tumor tissue volume， and it was significantly dose-dependent （Table 1）.

3.2. hGC-MSCs regulated the expression of Ki-67， PCNA，Bcl-2 and Bax in tumor tissue

Different doses of hGC-MSCs could all increase the expression of Ki-67， PCNA and Bcl-2， and inhibit the expression of Bax in tumor tissue. mRNA contents of Ki-67， PCNA and Bcl-2 in tumor tissue of hGC-MSCs group were higher than those of PBS group， and mRNA content of Bax was lower than that of PBS group； the larger the dose of hGC-MSCs， the more significant the change in the mRNA contents of Ki-67， PCNA， Bcl-2 and Bax， and it was significantlydose-dependent （Table 2）.

Table 1Tumor tissue volume of all groups （cm3）.

Table 2mRNA contents of proliferation-related molecules in tumor tissue of every group.

3.3. hGC-MSCs regulated the expression of MMPs and TIMPs in tumor tissue

Different doses of hGC-MSCs could all increase the expression of MMP-2， MMP-7， MMP-9 and MMP-14， and inhibit the expression of TIMP1 and TIMP2in tumor tissue. mRNA contents of MMP-2，MMP-7， MMP-9 and MMP-14 in tumor tissue of hGC-MSCs group were higher than those of PBS group， and mRNA contents of TIMP1 and TIMP2 were lower than those of PBS group； the larger the dose of hGC-MSCs， the more significant the change in the mRNA contents of MMP-2， MMP-7， MMP-9， MMP-14， TIMP1 and TIMP2， and it was significantly dose-dependent （Table 3）.

3.4. hGC-MSCs regulated the expression of EMT-related molecules in tumor tissue

Different doses of hGC-MSCs could all increase the expression of N-cadherin， Vimentin， Snail and Twist， and inhibit the expression of E-cadherin in tumor tissue. mRNA contents of N-cadherin， Vimentin， Snail and Twist in tumor tissue of hGC-MSCs group were higher than those of PBS group， and mRNA content of E-cadherin was lower than that of PBS group； the larger the dose of hGC-MSCs，the more significant the change in the mRNA contents of E-cadherin，N-cadherin， Vimentin， Snail and Twist， and it was significantly dosedependent （Table 4）.

4. Discussion

Mesenchymal stem cells （MSCs） are a kind of adult stem cells with features such as highly self-renewal ability， easily transferring into exogenous genes and oncolytic virus， and weak immunogenicity，and are associated with the pathogenesis of a variety of malignant solid tumors. Studies believe that gastric cancer stem cells are derived from stem cells in the gastrointestinal tract， and the above stem cells are in the undifferentiated state from early embryo development， or dedifferentiated from mature embryos ［6-7］； other studies have confirmed that gastric cancer stem cells are from bone marrow mesenchymal stem cell （BMSC）， and BMSC can switch phenotype and become cancer stem cells causing gastric cancer［8-9］. Mesenchymal stem cells have good affinity to tumors， and can interplay and interact with tumor microenvironment after affinity to tumor tissue， which can not only adjust the biological characteristics of tumor cells， but can also change the biological characteristics of their own ［10-13］.

The relationship between MSCs and the occurrence and development of gastric cancer has received more and more attention and recognition， but most of the studies about MSCs and gastric cancer use MSCs from normal bone marrow， and cannot fully simulate the biological characteristics of MSCs in tumor microenvironment. Study has confirmed that compared with bonemesenchymal stem cells （BMSCs） from normal bone marrow， the expression of a variety of genes in mesenchymal stem cells （hGCMSCs） from human gastric cancer tissue changes， and proliferation，invasion and other biological characteristics are also different ［14］. In the study， hGC-MSCs were isolated from fresh human gastric cancer tissue and cultured， hGC-MSCs were injected around the tumor after establishment of gastric cancer tumor-bearing mouse model，and measuring the volume of tumors showed that hGC-MSCs could promote the growth of gastric cancer tissue in dose-dependent manner.

Table 4mRNA contents of EMT-related molecules in tumor tissue of every group.

In the process of gastric cancer tissue growth， tumor cell proliferation， invasion and other biological behaviors are significantly enhanced， and the expression of a variety of proliferation and invasion-related molecules in tumor tissue is abnormal. HGCMSCs can regulate the biological behavior of tumor cells， and in order to determine whether hGC-MSCs regulated the expression of proliferation and invasion-related molecules so as to affect the biological behavior of tumor cells， the contents of biological characteristics-related molecules in tumor proliferation were determined. PCNA is the accessory protein for DNA polymerase to be functioning， is the molecule necessary for intracellular DNA replication and cell proliferation， Ki-67 is the molecule closely related to the function of chromatin， and PCNA and Ki-67 are used as cell proliferation markers ［15-16］. Bcl-2 and Bax are the key molecules regulating mitochondrial apoptosis， Bcl-2 can adjust the opening and closing of the mitochondrial membrane transition pore， reduce the release of cytochrome C and restrain the activation of apoptotic pathways， and Bax can form heterodimer with Bcl-2 to antagonize the antiapoptotic effect of Bcl-2 and promote cell apoptosis ［17-18］. Analysis in the study showed that different doses of hGC-MSCs could all increase the expression of Ki-67， PCNA and Bcl-2， and inhibit the expression of Bax and P53 in tumor tissue.

Cancer cell invasion is a key link causing tumor tissue growth and distant metastasis， and can degrade and destruct the structural barrier formed by extracellular matrix and vascular wall basement membrane， invade the microcirculation and migrate to the distant. Matrix metalloproteinases （MMPs） play a major role in cell degradation of extracellular matrix ［19］. MMP-2， MMP-7， MMP-9 and MMP-14 are the important members of MMPs family， and can degrade the composition such as collagen and laminin in the extracellular matrix. In addition， MMP-14 can also activate MMP2，MMP9 and various other protease molecules ［20］. Tissue inhibitor of metalloproteases （TIMPs） are the inhibitors of MMPs， and TIMP1 and TIMP2 can form covalent bonding with a variety of MMPs molecules to suppress their proteolysis function. Studies have confirmed that high expression of MMPs and lower expression of TIMPs are the important parts causing the occurrence and development of gastric cancer ［21-22］. The analysis in the study showed that different doses of hGC-MSCs could increase the expression of MMP-2， MMP-7， MMP-9 and MMP-14， and inhibit the expression of TIMP1 and TIMP2 in tumor tissue.

Epithelial-mesenchymal transition （EMT） is an important pathological feature in the occurrence and development of gastric cancer cells， specifically refers to the phenomenon of epithelial cell differentiation to mesenchymal cells under certain conditions，and is specifically manifested that the epithelial cells lose polarity，cells get strong movement ability and intercellular adhesion ability is decreased ［23-24］. E-cadherin is epithelial cell marker that can maintain cell polarity and adhesion； N-cadherin and Vimentin are mesenchymal markers that can enhance cell migration and invasion， and cause invasive cell growth ［25］. In the process of EMT， epithelial cells transit to mesenchymal cells， the expression of E-cadherin is decreased significantly and the expression of N-cadherin and Vimentin is increased significantly. Snail and Twist are two transcription factors regulating cell EMT process， and can be combined with the DNA sequences of epithelial cell and mesenchymal cell markers to adjust their transcription and thus promote cell EMT ［26-27］. In the study， analysis of EMT in gastric cancer tissue of tumor-bearing mice showed that different doses of hGC-MSCs could all promote the process of EMT in gastric cancer tissue， increase the expression of N-cadherin， Vimentin， Snail and Twist， and inhibit the expression of E-cadherin.

To sum up， hGC-MSCs from human gastric cancer tissue can promote the tumor growth in gastric cancer tumor-bearing mice，and the molecular mechanism includes promoting cell proliferation，invasion and epithelial-mesenchymal transition.

Conflict of interest statement

We declare that we have no conflict on interest.

［1］ Mabuchi Y， Matsuzaki Y. Prospective isolation of resident adult human mesenchymal stem cell population from multiple organs. Int J Hematol 2016； 103（2）：138-144.

［2］ Muntión S， Ramos TL， Diez-Campelo M， Rosón B， Sánchez-Abarca LI，Misiewicz-Krzeminska I， et al. microvesicles from mesenchymal stromal cells are involved in hpc-microenvironment crosstalk in myelodysplastic patients. PLoS One 2016；11（2）： e0146722.

［3］ Lee MS， Yuan H， Jeon H， Zhu Y， Yoo S， Shi S， et al. human mesenchymal stem cells of diverse origins support persistent infection with kaposi's sarcoma-associated herpesvirus and manifest distinct angiogenic， invasive，and transforming phenotypes. MBio 2016；7（1）： e02109-15.

［4］ Cammarota F， Laukkanen MO. Mesenchymal stem/stromal cells in stromal evolution and cancer progression. Stem Cells Int 2016；2016：4824573.

［5］ Cheng J， Yang K， Zhang Q， Yu Y， Meng Q， Mo N， et al. The role of mesenchymal stem cells in promoting the transformation of androgendependent human prostate cancer cells into androgen-independent manner. Sci Rep 2016；20（6）：16993.

［6］ Kasashima H， Yashiro M， Nakamae H， Masuda G， Kinoshita H， Morisaki T， et al. Bone marrow-derived stromal cells are associated with gastric cancer progression. Br J Cancer 2015；113（3）： 443-452.

［7］ Sun X， Zou Y， Hao Y， Zhou C， Meng X. Pathological analysis of collision（double primary） cancer in the upper digestive tract concomitant with gastric stromal tumor： a case report. Int J Clin Exp Pathol 2015；8（10）：13523-13527.

［8］ Li W， Zhou Y， Yang J， Zhang X， Zhang H， Zhang T， et al. Gastric cancerderived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. J Exp Clin Cancer Res 2015；20（34）： 52.

［9］ Zhao Y， Feng F， Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015；21（1）：112-123.

［10］ Xue Z， Wu X， Chen X， Liu Y， Wang X， Wu K， et al. Mesenchymal stem cells promote epithelial to mesenchymal transition and metastasis in gastric cancer though paracrine cues and close physical contact. J Cell Biochem 2015； 116（4）：618-627.

［11］ Song B ， Kim B ， Choi SH ， Song KY， Chung YG ， Lee YS ， et al. Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean J Pathol 2014；48（3）：217-224.

［12］ Huang F， Wang M， Yang T， Cai J， Zhang Q， Sun Z， et al. Gastric cancerderived MSC-secreted PDGF-DD promotes gastric cancer progression. J Cancer Res Clin Oncol 2014；140（11）：1835-1848.

［13］ Wang Jia， Yu Jiwei， Wu Jugang， Wang Shoulian， Chen Dehu， Yang Fan，et al. Experimental study of human bone marrow mesenchymal stem cells on regulating the biological characteristics of gastric cancer cells. Chin J Gastrointest Surg 2015；18（2）： 159-163.

［14］ Xu X， Zhang X， Wang S， Qian H， Zhu W， Cao H， et al. Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol 2011；137（3）：495-504.

［15］ Li N， Deng W， Ma J， Wei B， Guo K， Shen W， et al. Prognostic evaluation of Nanog， Oct4， Sox2， PCNA， Ki67 and E-cadherin expression in gastric cancer. Med Oncol 2015；32（1）：433.

［16］ K?m?lo lu ahan E ， Erdo an N， Ulusoy ， Samet E， Aky?ld ?z dem A，G?nüllü D. P53， KI-67， CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters. Turk J Gastroenterol 2015； 26（2）：104-111.

［17］ Zhou Y， Li Y， Zheng J， Liu K， Zhang H. Detecting of gastric cancer by Bcl-2 and Ki67. Int J Clin Exp Pathol 2015； 8（6）：7287-7290.

［18］ Wang X ， Lin Y， Lan F， Yu Y， Ouyang X ， Liu W， et al. BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy. Med Oncol 2014；31（11）：249.

［19］ Kim TH， Jung JY， Roh HJ， Chung KY， Roh MR. Comparative expression of matrix metalloproteinases in internal malignancies and paired cutaneous metastatic lesions. Am J Dermatopathol 2015； 37（5）：381-388.

［20］ Gurgel DC， Valen?a-Junior JT， Dornelas CA， Vieira RB， Maia-Filho JT，Lima-Junior RC， et al. Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis. Pathol Oncol Res 2015； 21（1）：73-81.

［21］ Zhang Jin-ling， Fei Yan， Chen Wei， Feng Gang. Expression of MMP-2，MMP-14 and TIMP-2 in gastric cancer and its clinical significance. Acta Medicinae Universitatis Scientiae Et Technologiae Huazhong 2013；42（2）：227-230.

［22］ Tan Bi-Bo， Li Yong， Zhao Qun， Faf Li-Qiao ， Liu Xiao-Hui， Jiao Zhikai， et al. Relationship between zinc finger protein 139 with matrix metalloproteinase-2， matrix metailoproteinase-7 and tissue inhibitor of metalloproteinase-1 in local lymph node metastases of gastric cancer. Chin J Experim Surg 2013； 30（5）： 951-953.

［23］ Li TT， Liu H ， Li FP， Hu YF， Mou TY， Lin T， et al. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer： Relevance to therapy response. World J Gastroenterol 2015；21（47）：13259-13267.

［24］ Xue J， Zhu Y， Sun Z ， Ji R ， Zhang X ， Xu W， et al. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation， migration and stemness. BMC Cancer 2015；24（15）：793.

［25］ Huang L， Wu RL， Xu AM. Epithelial-mesenchymal transition in gastric cancer. Am J Transl Res 2015； 7（11）：2141-2158.

［26］ Zhu DY， Guo QS， Li YL， Cui B， Guo J， Liu JX， et al. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression. World J Gastroenterol 2014；20（48）：18306-18315.

［27］ Cho HJ， Park SM， Kim IK， Nam IK， Baek KE， Im MJ， et al. RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cells. Oncotarget 2014；5（6）：1554-1564.

10.1016/j.apjtm.2016.06.004

Lin Song， Oncology Department No. 2， Linyi People’s Hospital of Shandong Province， Linyi City， Shandong Province， 276000 China.

Tel： 13697816230

E-mail：

?Corresponding author： Hong-Jun JIA， Radiotherapy Technology Department，Linyi People’s Hospital of Shandong Province， Linyi City， Shandong Province，276000 China.

Tel： 13805490657

E-mail： jiahongjun1968@yeah.net

Foundation project： This study was supported by Science and Technology Development Program of Linyi City in 2014 （grant No. Linkezi No. 18 201413010）.

ARTICLE INFO